Will joined Downing in August 2018 where he directs the healthcare activities of the Downing venture funds. Will has over 30 years’ experience in healthcare and biotechnology with over 18 years’ experience in venture capital across Europe and the U.S. After studying in Glasgow and Dundee he did 7 years post-doctoral research at the University of Munich before joining London based biotechnology company Antisoma. He then moved to Brussels where for over 10 years he ran the healthcare investments for Quest for Growth a large pan European cross over fund.
Current role